Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation

Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation

US Patent 5783591 · Granted Jul 21, 1998

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor 2011
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) recepto2011
Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumo2010
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines2009
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) recepto2009
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines2009
Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitor2009
N-oxide anthranylamide derivatives and their use as medicaments2008
Cyanoanthranilamide derivatives and the use thereof as medicaments2008
Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumo2008
Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process2007
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones2007